Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Vogelstein, B. AU - Lane, D. AU - Levine, A.J. TI - Surfing the p53 network JO - Nature PY - 2000/// VL - 408 SP - 307 EP - 310 M3 - 10.1038/35042675 N1 - 10.1038/35042675 UR - http://dx.doi.org/10.1038/35042675 ER - TY - JOUR AU - Olivier, M. TI - The IARC TP53 database: new online mutation analysis and recommendations to users JO - Hum. Mutat. PY - 2002/// VL - 19 SP - 607 EP - 614 M3 - 10.1002/humu.10081 N1 - 10.1002/humu.10081 UR - http://dx.doi.org/10.1002/humu.10081 ER - TY - JOUR AU - Chene, P. TI - Inhibiting the p53[ndash]MDM2 interaction: an important target for cancer therapy JO - Nat. Rev. Cancer PY - 2003/// VL - 3 SP - 102 EP - 109 M3 - 10.1038/nrc991 N1 - 10.1038/nrc991 UR - http://dx.doi.org/10.1038/nrc991 ER - TY - JOUR AU - Prives, C. TI - Signaling to p53: breaking the MDM2-p53 circuit JO - Cell PY - 1998/// VL - 95 SP - 5 EP - 8 M3 - 10.1016/S0092-8674(00)81774-2 N1 - 10.1016/S0092-8674(00)81774-2 UR - http://dx.doi.org/10.1016/S0092-8674(00)81774-2 ER - TY - JOUR AU - Montes de Oca Luna, R. AU - Wagner, D.S. AU - Lozano, G. TI - Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 JO - Nature PY - 1995/// VL - 378 SP - 203 EP - 206 M3 - 10.1038/378203a0 N1 - 10.1038/378203a0 UR - http://dx.doi.org/10.1038/378203a0 ER - TY - JOUR AU - Vousden, K.H. TI - Activation of the p53 tumor suppressor protein JO - Biochim. Biophys. Acta PY - 2002/// VL - 1602 SP - 47 EP - 59 M3 - 10.1016/S0304-419X(02)00035-5 N1 - 10.1016/S0304-419X(02)00035-5 UR - http://dx.doi.org/10.1016/S0304-419X(02)00035-5 ER - TY - JOUR AU - Evan, G. AU - Littlewood, T. TI - A matter of life and cell death JO - Science PY - 1998/// VL - 281 SP - 1317 EP - 1322 M3 - 10.1126/science.281.5381.1317 N1 - 10.1126/science.281.5381.1317 UR - http://dx.doi.org/10.1126/science.281.5381.1317 ER - TY - JOUR AU - Bottger, A. TI - Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo JO - Curr. Biol. PY - 1997/// VL - 7 SP - 860 EP - 869 M3 - 10.1016/S0960-9822(06)00374-5 N1 - 10.1016/S0960-9822(06)00374-5 UR - http://dx.doi.org/10.1016/S0960-9822(06)00374-5 ER - TY - JOUR AU - Chene, P. TI - A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines JO - J. Mol. Biol. PY - 2000/// VL - 299 SP - 245 EP - 253 M3 - 10.1006/jmbi.2000.3738 N1 - 10.1006/jmbi.2000.3738 UR - http://dx.doi.org/10.1006/jmbi.2000.3738 ER - TY - JOUR AU - Midgley, C.A. TI - An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo JO - Oncogene PY - 2000/// VL - 19 SP - 2312 EP - 2323 M3 - 10.1038/sj.onc.1203593 N1 - 10.1038/sj.onc.1203593 UR - http://dx.doi.org/10.1038/sj.onc.1203593 ER - TY - JOUR AU - Lai, Z. TI - Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors JO - Proc. Natl. Acad. Sci. USA PY - 2002/// VL - 99 SP - 14734 EP - 14739 M3 - 10.1073/pnas.212428599 N1 - 10.1073/pnas.212428599 UR - http://dx.doi.org/10.1073/pnas.212428599 ER - TY - JOUR AU - Zhao, J. TI - The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53[ndash]HDM2 complex structure JO - Cancer Lett. PY - 2002/// VL - 183 SP - 69 EP - 77 M3 - 10.1016/S0304-3835(02)00084-8 N1 - 10.1016/S0304-3835(02)00084-8 UR - http://dx.doi.org/10.1016/S0304-3835(02)00084-8 ER - TY - JOUR AU - Vassilev, L.T. TI - In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 JO - Science PY - 2004/// VL - 303 SP - 844 EP - 848 M3 - 10.1126/science.1092472 N1 - 10.1126/science.1092472 UR - http://dx.doi.org/10.1126/science.1092472 ER - TY - JOUR AU - Bunz, F. TI - Requirement for p53 and p21 to sustain G2 arrest after DNA damage JO - Science PY - 1998/// VL - 282 SP - 1497 EP - 1501 M3 - 10.1126/science.282.5393.1497 N1 - 10.1126/science.282.5393.1497 UR - http://dx.doi.org/10.1126/science.282.5393.1497 ER - TY - JOUR AU - Bunz, F. TI - Disruption of p53 in human cancer cells alters the responses to therapeutic agents JO - J. Clin. Invest. PY - 1999/// VL - 104 SP - 263 EP - 269 ER - TY - JOUR AU - Rigler, R. TI - Specific binding of proinsulin C-peptide to human cell membranes JO - Proc. Natl. Acad. Sci. USA PY - 1999/// VL - 96 SP - 13318 EP - 13323 M3 - 10.1073/pnas.96.23.13318 N1 - 10.1073/pnas.96.23.13318 UR - http://dx.doi.org/10.1073/pnas.96.23.13318 ER - TY - JOUR AU - Yakovleva, T. TI - p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences JO - J. Biol. Chem. PY - 2001/// VL - 276 SP - 15650 EP - 15658 M3 - 10.1074/jbc.M100482200 N1 - 10.1074/jbc.M100482200 UR - http://dx.doi.org/10.1074/jbc.M100482200 ER - TY - JOUR AU - Wang, L. AU - Grossman, S.R. AU - Kieff, E. TI - Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter JO - Proc. Natl. Acad. Sci. USA PY - 2000/// VL - 97 SP - 430 EP - 435 M3 - 10.1073/pnas.97.1.430 N1 - 10.1073/pnas.97.1.430 UR - http://dx.doi.org/10.1073/pnas.97.1.430 ER - TY - JOUR AU - Lin, J. AU - Chen, J. AU - Elenbaas, B. AU - Levine, A.J. TI - Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kDa protein JO - Genes Dev. PY - 1994/// VL - 8 SP - 1235 EP - 1246 ER - TY - JOUR AU - Kussie, P.H. TI - Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain JO - Science PY - 1996/// VL - 274 SP - 948 EP - 953 M3 - 10.1126/science.274.5289.948 N1 - 10.1126/science.274.5289.948 UR - http://dx.doi.org/10.1126/science.274.5289.948 ER - TY - JOUR AU - Burch, L.R. AU - Midgley, C.A. AU - Currie, R.A. AU - Lane, D.P. AU - Hupp, T.R. TI - Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA JO - FEBS Lett. PY - 2000/// VL - 472 SP - 93 EP - 98 M3 - 10.1016/S0014-5793(00)01427-7 N1 - 10.1016/S0014-5793(00)01427-7 UR - http://dx.doi.org/10.1016/S0014-5793(00)01427-7 ER - TY - JOUR AU - Kanovsky, M. TI - Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells JO - Proc. Natl. Acad. Sci. USA PY - 2001/// VL - 98 SP - 12438 EP - 12443 M3 - 10.1073/pnas.211280698 N1 - 10.1073/pnas.211280698 UR - http://dx.doi.org/10.1073/pnas.211280698 ER - TY - JOUR AU - Gu, W. AU - Roeder, R.G. TI - Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain JO - Cell PY - 1997/// VL - 90 SP - 595 EP - 606 M3 - 10.1016/S0092-8674(00)80521-8 N1 - 10.1016/S0092-8674(00)80521-8 UR - http://dx.doi.org/10.1016/S0092-8674(00)80521-8 ER - TY - JOUR AU - Grossman, S.R. TI - Polyubiquitination of p53 by a ubiquitin ligase activity of p300 JO - Science PY - 2003/// VL - 300 SP - 342 EP - 344 M3 - 10.1126/science.1080386 N1 - 10.1126/science.1080386 UR - http://dx.doi.org/10.1126/science.1080386 ER - TY - JOUR AU - Bergamaschi, D. TI - iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human JO - Nat. Genet. PY - 2003/// VL - 33 SP - 162 EP - 167 M3 - 10.1038/ng1070 N1 - 10.1038/ng1070 UR - http://dx.doi.org/10.1038/ng1070 ER - TY - JOUR AU - Mihara, M. TI - p53 has a direct apoptogenic role at the mitochondria JO - Mol. Cell PY - 2003/// VL - 11 SP - 577 EP - 590 M3 - 10.1016/S1097-2765(03)00050-9 N1 - 10.1016/S1097-2765(03)00050-9 UR - http://dx.doi.org/10.1016/S1097-2765(03)00050-9 ER - TY - JOUR AU - Nikolaev, A.Y. AU - Li, M. AU - Puskas, N. AU - Qin, J. AU - Gu, W. TI - Parc: a cytoplasmic anchor for p53 JO - Cell PY - 2003/// VL - 112 SP - 29 EP - 40 M3 - 10.1016/S0092-8674(02)01255-2 N1 - 10.1016/S0092-8674(02)01255-2 UR - http://dx.doi.org/10.1016/S0092-8674(02)01255-2 ER - TY - JOUR AU - Pandhare, J. AU - Dash, C. AU - Rao, M. AU - Deshpande, V. TI - Slow tight binding inhibition of proteinase K by a proteinaceous inhibitor: conformational alterations responsible for conferring irreversibility to the enzyme-inhibitor complex JO - J. Biol. Chem. PY - 2003/// VL - 278 SP - 48735 EP - 48744 M3 - 10.1074/jbc.M308976200 N1 - 10.1074/jbc.M308976200 UR - http://dx.doi.org/10.1074/jbc.M308976200 ER - TY - JOUR AU - Jabbur, J.R. TI - Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21 JO - Oncogene PY - 2002/// VL - 21 SP - 7100 EP - 7113 M3 - 10.1038/sj.onc.1205856 N1 - 10.1038/sj.onc.1205856 UR - http://dx.doi.org/10.1038/sj.onc.1205856 ER - TY - JOUR AU - Iyer, N.G. TI - p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels JO - Proc. Natl. Acad. Sci. USA PY - 2004/// VL - 101 SP - 7386 EP - 7391 M3 - 10.1073/pnas.0401002101 N1 - 10.1073/pnas.0401002101 UR - http://dx.doi.org/10.1073/pnas.0401002101 ER - TY - JOUR AU - Grossman, S.R. TI - p300/MDM2 complexes participate in MDM2-mediated p53 degradation JO - Mol. Cell PY - 1998/// VL - 2 SP - 405 EP - 415 M3 - 10.1016/S1097-2765(00)80140-9 N1 - 10.1016/S1097-2765(00)80140-9 UR - http://dx.doi.org/10.1016/S1097-2765(00)80140-9 ER - TY - JOUR AU - Liu, W.L. AU - Midgley, C. AU - Stephen, C. AU - Saville, M. AU - Lane, D.P. TI - Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein JO - J. Mol. Biol. PY - 2001/// VL - 313 SP - 711 EP - 731 M3 - 10.1006/jmbi.2001.5082 N1 - 10.1006/jmbi.2001.5082 UR - http://dx.doi.org/10.1006/jmbi.2001.5082 ER - TY - JOUR AU - Friedlander, P. AU - Legros, Y. AU - Soussi, T. AU - Prives, C. TI - Regulation of mutant p53 temperature-sensitive DNA binding JO - J. Biol. Chem. PY - 1996/// VL - 271 SP - 25468 EP - 25478 M3 - 10.1074/jbc.271.41.25468 N1 - 10.1074/jbc.271.41.25468 UR - http://dx.doi.org/10.1074/jbc.271.41.25468 ER - TY - JOUR AU - Hansen, S. AU - Hupp, T.R. AU - Lane, D.P. TI - Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group JO - J. Biol. Chem. PY - 1996/// VL - 271 SP - 3917 EP - 3924 M3 - 10.1074/jbc.271.7.3917 N1 - 10.1074/jbc.271.7.3917 UR - http://dx.doi.org/10.1074/jbc.271.7.3917 ER - TY - JOUR AU - Cho, Y. AU - Gorina, S. AU - Jeffrey, P.D. AU - Pavletich, N.P. TI - Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations JO - Science PY - 1994/// VL - 265 SP - 346 EP - 355 ER - TY - JOUR AU - Jeffrey, P.D. AU - Gorina, S. AU - Pavletich, N.P. TI - Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms JO - Science PY - 1995/// VL - 267 SP - 1498 EP - 14502 ER - TY - JOUR AU - Lee, W. TI - Solution structure of the tetrameric minimum transforming domain of p53 JO - Nat. Struct. Biol. PY - 1994/// VL - 1 SP - 877 EP - 890 M3 - 10.1038/nsb1294-877 N1 - 10.1038/nsb1294-877 UR - http://dx.doi.org/10.1038/nsb1294-877 ER - TY - JOUR AU - Baker, S.J. AU - Markowitz, S. AU - Fearon, E.R. AU - Willson, J.K. AU - Vogelstein, B. TI - Suppression of human colorectal carcinoma cell growth by wild-type p53 JO - Science PY - 1990/// VL - 249 SP - 912 EP - 915 ER - TY - JOUR AU - D'Orazi, G. TI - Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting JO - J. Gene Med. PY - 2000/// VL - 2 SP - 11 EP - 21 M3 - 10.1002/(SICI)1521-2254(200001/02)2:1<11::AID-JGM81>3.3.CO;2-B N1 - 10.1002/(SICI)1521-2254(200001/02)2:1<11::AID-JGM81>3.3.CO;2-B UR - http://dx.doi.org/10.1002/(SICI)1521-2254(200001/02)2:1<11::AID-JGM81>3.3.CO;2-B ER - TY - JOUR AU - Nieves-Neira, W. TI - DNA protein cross-links produced by NSC 652287, a novel thiophene derivative active against human renal cancer cells JO - Mol. Pharmacol. PY - 1999/// VL - 56 SP - 478 EP - 484 ER - TY - JOUR AU - Rivera, M.I. TI - Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: differential accumulation and metabolism JO - Biochem. Pharmacol. PY - 1999/// VL - 57 SP - 1283 EP - 1295 M3 - 10.1016/S0006-2952(99)00046-5 N1 - 10.1016/S0006-2952(99)00046-5 UR - http://dx.doi.org/10.1016/S0006-2952(99)00046-5 ER - TY - JOUR AU - Selivanova, G. TI - The single-stranded DNA end binding site of p53 coincides with the C- terminal regulatory region JO - Nucleic Acids Res. PY - 1996/// VL - 24 SP - 3560 EP - 3567 M3 - 10.1093/nar/24.18.3560 N1 - 10.1093/nar/24.18.3560 UR - http://dx.doi.org/10.1093/nar/24.18.3560 ER - TY - JOUR AU - Schuhmacher, M. TI - Control of cell growth by c-Myc in the absence of cell division JO - Curr. Biol. PY - 1999/// VL - 9 SP - 1255 EP - 1258 M3 - 10.1016/S0960-9822(99)80507-7 N1 - 10.1016/S0960-9822(99)80507-7 UR - http://dx.doi.org/10.1016/S0960-9822(99)80507-7 ER - TY - JOUR AU - Felsher, D.W. AU - Bishop, J.M. TI - Transient excess of MYC activity can elicit genomic instability and tumorigenesis JO - Proc. Natl. Acad. Sci. USA PY - 1999/// VL - 96 SP - 3940 EP - 3944 M3 - 10.1073/pnas.96.7.3940 N1 - 10.1073/pnas.96.7.3940 UR - http://dx.doi.org/10.1073/pnas.96.7.3940 ER - TY - JOUR AU - Vigo, E. TI - CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase JO - Mol. Cell. Biol. PY - 1999/// VL - 19 SP - 6379 EP - 6395 ER - TY - JOUR AU - Hengstermann, A. AU - Linares, L.K. AU - Ciechanover, A. AU - Whitaker, N.J. AU - Scheffner, M. TI - Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells JO - Proc. Natl. Acad. Sci. USA PY - 2001/// VL - 98 SP - 1218 EP - 1223 M3 - 10.1073/pnas.031470698 N1 - 10.1073/pnas.031470698 UR - http://dx.doi.org/10.1073/pnas.031470698 ER -